Expert second opinions for endocarditis. Dual-physician Heart Team review with triple risk scoring. Results in 24 hours.
Endocarditis ocarditis is an infection of the heart valves with significant morbidity and mortality. If you are facing a decision about endocarditis, an independent Heart Team second opinion can confirm whether surgery is the right choice and identify alternatives. WhiteGloveMD delivers dual-physician review with STS, EuroSCORE II, and AATS risk scoring in 24 hours. Get an independent second opinion →
Infective endocarditis is an infection of the heart valves with significant morbidity and mortality. Despite advances in antibiotic therapy, surgery is required in approximately 50% of cases. The decision of when to operate — early vs after prolonged antibiotics — profoundly affects outcomes.
Endocarditis surgery is time-sensitive and technically challenging. Early surgery (within days of diagnosis) has been shown to reduce mortality and embolic events in select patients, but not all cases benefit from urgent operation. The interplay between vegetation size, embolic risk, heart failure, and infection control requires expert multidisciplinary judgment.
Surgery for endocarditis depends on symptom severity, imaging findings, and risk profile. Guidelines from the AHA/ACC define specific thresholds, but many patients fall into gray zones where a second opinion meaningfully changes the recommendation. Endocarditis surgery is time-sensitive and technically challenging. Early surgery (within days of diagnosis) has been shown to reduce mortality and embolic events in select patients, but not all cases benefit from urgent operation. The interplay between vegetation size, embolic risk, heart failure, and infection control requires expert multidisciplinary judgment.
Operative mortality for endocarditis-related cardiac surgery is calculated using validated models including STS PROM, EuroSCORE II, and AATS. Individual risk depends on age, comorbidities, frailty, ejection fraction, and surgeon/center volume. Our free calculator at whiteglovemd.com/tools/risk-calculator estimates your specific risk across all three models in real time.
Yes. Studies show that 30-40% of expert cardiac surgery second opinions change the original treatment plan — sometimes by recommending less-invasive alternatives, sometimes by clarifying that watchful waiting is safer. WhiteGloveMD pairs a cardiac surgeon and cardiologist with our Clintelligence multi-agent AI pipeline to deliver an independent review in 24 hours, starting at $500.
The optimal treatment for endocarditis depends on anatomy, comorbidities, age, and personal goals. Early vs delayed surgical intervention. A Heart Team review evaluates every viable option — including transcatheter approaches, repair vs replacement, and surgeon/center matching — rather than defaulting to a single recommendation.
WhiteGloveMD delivers a dual-physician, AI-augmented second opinion in 24 hours. Starting at $500.